Search
Alanine
go.drugbank.com/drugs/DB00160ApprovedInvestigationalNutraceuticalIt is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system.
Mixtures: Clinimix E, Clinimix ELofexidine
go.drugbank.com/drugs/DB04948ApprovedInvestigational[T210] Lofexidine was then repurposed for the treatment of opioid withdrawal, as it was seen to be more economical and have fewer side effects than clonidine. … Lofexidine is a non-opioid centrally acting alpha2-adrenergic receptor agonist that was first approved for the treatment of opioid withdrawal in the United Kingdom in 1992.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeMinaprine
go.drugbank.com/drugs/DB00805ApprovedMinaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states. Like most antidepressants minaprine antagonizes behavioral despair. … Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeNystatin
go.drugbank.com/drugs/DB00646ApprovedInvestigationalVet approved[L10686] It is one of the most effective antifungal agents synthesized by bacteria, in this case a strain of _Streptomyces noursei_,[L10776] and is closely related to [amphotericin B], differing only slightly … [A188562] As it undergoes very little absorption following oral or topical administration, nystatin's efficacy is limited to the treatment/prevention of cutaneous, mucocutaneous, and gastrointestinal fungal
Mixtures: GYNECON - T, NISTATINA + OXIDO DE ZINCTibolone
go.drugbank.com/drugs/DB09070ApprovedInvestigationalTibolone is approved in 90 countries to manage menopausal symptoms and in 45 countries to prevent the development of osteoporosis [L1876]. … In June 2006, Organon Pharmaceuticals announced the receipt of a Not Approvable Letter from the U.S.
Categories: Sex Hormones and Modulators of the Genital SystemRisperidone
go.drugbank.com/drugs/DB00734ApprovedInvestigational[L12885] Risperidone binds with a very high affinity to 5-HT2A receptors, approximately 10-20 fold greater than the drug's binding affinity to D2 receptors, and carries lesser activity at several off-targets … Risperidone is thought to reduce this overactivity through inhibition of dopaminergic D2 receptors and serotonergic 5-HT2A receptors in the brain.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: RISPERDAL QUICLKET ® TABLETAS DE 0.5 MG, RISPERDAL QUICKLET ® TABLETAS DE 2.0 MGAmineptine
go.drugbank.com/drugs/DB04836ApprovedIllicitWithdrawnThe Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeEscitalopram
go.drugbank.com/drugs/DB01175ApprovedInvestigationalto other SSRIs. … [A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeChondroitin sulfate
go.drugbank.com/drugs/DB09301ApprovedInvestigationalNutraceutical[A7906] The SYSADOA status suggested a pain relief and increased joint mobility after a relative long regular administration, as well as a long-lasting effect after the end of the treatment. … Depending on the predominating disaccharide unit, it will present different biological activities.
Mixtures: FLEXURE®CAPSULA DE GELATINA, FLEXURE®CAPSULA DE GELATINAMephentermine
go.drugbank.com/drugs/DB01365ApprovedWithdrawnAlthough the central stimulant effects of mephentermine are much less than those of amphetamine, its use may lead to amphetamine-type dependence. … (From Martindale, The Extra Pharmacopoeia, 30th ed, p1248)
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome